Observational Study of RAS monitoring for RAS/BRAF wild advanced Colorectal Cancer Patients treated with anti EGFR antibody

ABSTRACT: Primary outcome(s): Time to RAS mutations acquired

DISEASE(S): Colorectal Cancer,Ras Braf Psskit Sysmex

PROVIDER: 2612955 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR